Heartflow, Inc. Increase (Decrease) in Accounts Receivable
Heartflow, Inc. (HTFL) reported Increase (Decrease) in Accounts Receivable of $13.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-13
- Heartflow, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $7.23M, a 466.93% increase year-over-year.
- Heartflow, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $6.18M, a 71.73% increase year-over-year.
- Heartflow, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $1.84M, a 40.76% increase year-over-year.
- Heartflow, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$1.83M.
- Heartflow, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $4.89M, a 27.10% increase from fiscal 2024.
- Heartflow, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $3.85M, a 58.83% decline from fiscal 2023.
- Heartflow, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $9.35M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $13.42M 10-Q · filed 2026-08-13 | $15.26M derived: sum of 3 quarters · filed 2026-08-13 | $13.43M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $6.18M 10-Q · filed 2026-05-14 | $8.03M derived: sum of 2 quarters · filed 2026-05-14 | $6.20M derived: sum of 3 quarters · filed 2026-05-14 | $7.47M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $15.00K derived: sum of 2 quarters · filed 2026-03-18 | $1.29M derived: sum of 3 quarters · filed 2026-08-13 | $4.89M 10-K · filed 2026-03-18 |
| 2025-09-30 | -$1.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$553.00K derived: sum of 2 quarters · filed 2026-08-13 | $3.05M 10-Q · filed 2025-11-12 | $4.36M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $4.88M 10-Q · filed 2026-08-13 | $6.19M derived: sum of 3 quarters · filed 2026-08-13 | $5.15M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $3.60M 10-Q · filed 2026-05-14 | $4.91M derived: sum of 2 quarters · filed 2026-05-14 | $3.88M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $276.00K derived: sum of 2 quarters · filed 2026-03-18 | $3.85M 10-K · filed 2026-03-18 | |
| 2024-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.54M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $3.57M 10-Q · filed 2025-09-19 | |||
| 2023-12-31 | $9.35M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |